Minority-focused Environmental Health Education and Tracking Pilot Study (MEET)

May 14, 2026 updated by: Jenna Hua, Million Marker Wellness, Inc.

Minority-focused Environmental Health Education and Tracking (MEET) Pilot Study

The goal of this study is identify educational material related to EDC exposures that is culturally appropriate for the black community and test the usability of the material. The main questions this study aims to answer are:

  1. identify problematic lifestyle behaviors and products in a minority population that may contribute to harmful exposures and subsequently determine the most effective and sustainable lifestyle recommendations to reduce exposures;
  2. develop culturally appropriate educational EDC EHL materials by collaborating with community groups and adapting from Million Marker's existing extensive online educational resources and recommendations;
  3. integrate developed educational materials and targeted recommendations in existing Million Marker platform and test the usability of the material using a cohort of 100 black community members.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Integrate and test the usability of MEET. Use design iteration process to integrate developed educational materials and targeted recommendations in existing Million Marker platform and test the usability of the material using a cohort of 100 black community members.

The education material and recommendations developed for this project updates/adds on to the current Million Marker educational platform. This updated platform, MEET will incorporate culturally-sensitive feedback for an African American population. MEET will utilize a friendly user interface, and multiple options for engagement and incorporation of science translation/education.

The investigators will use eligibility criteria to recruit additional study participants that are: a) aged 18 and older; b) able to understand written and spoken English; c) owning a smartphone; and d) willing to complete all study assessments. Recruitment will be assisted by BCI's community advisory board. Again, investigators will utilize existing BCI's network, mailing lists and social media promotion to recruit potential participants. The investigators expect to enroll approximately 50% women and 100% African American.

The feasibility and usability testing will be conducted virtually. Recruited and consented community members (n=100) will use the platform for 4 weeks. Pre and post surveys will completed at the beginning and after 4 weeks. Surveys will cover environmental health and internet literacy, health app use, readiness to change and perceived identity, product use and breast cancer risk. The survey results will identify gaps in user perception and awareness to inform our education and marketing strategies. The investigators hypothesize that participants' environmental health literacy, attitudes, knowledge and behaviors will change after using MEET and receiving their personalized recommendations. The changes in participants' behaviors will be compared and assessed by examining the changes in lifestyle behaviors and product use, which will be captured through participants' exposure journals. The investigators expect to see a reduction in using EDC containing products, touching receipts, using less plastics, etc. Participants will also fill out an adapted System Usability Score (SUS)79 to assess users' perception of usability of the platform. The investigators expect to obtain high SUS scores, and will address any deficiencies based on SUS results and user feedback. Follow up surveys will be compared in order to assess trends over time, and begin to incorporate user feedback and behavior into the platform. Information collected will also inform our Phase II grant and future research studies.

The investigators will assess changes in participants' environmental health literacy, attitudes, knowledge, and behaviors after using MEET. Summary statistics will be generated on participants' responses. Changes will be calculated based on paired values of individual responses. The investigators will analyze percentage changes by individual responses as well as response categories (attitude, knowledge and behaviors). A Chi-square goodness of fit test will be used for pre-post comparisons. For pre-post category comparisons within individual participants, the Wilcoxon rank-sum test will be used to compare the differences.

The expected sample size of 100 will provide sufficient power to detect a difference in participant behaviors and attitudes at baseline (before using MEET) and after using MEET.

Study Type

Interventional

Enrollment (Actual)

151

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • California
      • Berkeley, California, United States, 94704
        • Million Marker

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Identify as black
  • Have access to a smartphone or computer

Exclusion Criteria:

  • Do not identify as black
  • Do not have access to a smartphone or computer

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Black Community Participants
Members of the black community
Behavioral: Education curriculum
A self-directed online interactive curriculum of EDC material, with access to live coaches and an online forum.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in Endocrine Disrupting Chemical - Environmental Health Literacy (EDC-EHL) after the intervention.
Time Frame: Measured before the intervention, after the intervention (1 months after baseline), and at follow-up (1 months after the intervention)
This surveys assesses EDC-specific environmental health literacy, based on questions in a 5-point Likert scale from 1 (strongly agree) to 5 (strongly disagree) or 1 (never) to 5 (always). Responses will be reverse coded during analysis as needed so that higher numbers reflect positive outcomes (higher EDC-EHL).
Measured before the intervention, after the intervention (1 months after baseline), and at follow-up (1 months after the intervention)
Changes in 'Readiness to Change' to reduce risky behaviors after the intervention.
Time Frame: Measured before the intervention, after the intervention (1 months after baseline), and at follow-up (1 months after the intervention)
The Readiness to Change question asks participants to choose the response (sentence) that most accurately describes their current efforts and interest in limiting their exposure to harmful chemicals. Responses will be coded from 1 to 5 with 5 reflecting greater readiness to reduce risky behaviors.
Measured before the intervention, after the intervention (1 months after baseline), and at follow-up (1 months after the intervention)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Million Marker Wellness, Inc.

Collaborators

National Institute on Minority Health and Health Disparities (NIMHD)

Investigators

  • Study Director: Jayne Foley, MPPM, MPH, Million Marker Wellness

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2025

Primary Completion (Actual)

February 20, 2026

Study Completion (Actual)

February 20, 2026

Study Registration Dates

First Submitted

December 2, 2025

First Submitted That Met QC Criteria

March 9, 2026

First Posted (Actual)

March 10, 2026

Study Record Updates

Last Update Posted (Actual)

May 18, 2026

Last Update Submitted That Met QC Criteria

May 14, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 20252771
  • 1R43MD018950-01A1 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Sharing Time Frame

Starting six months after publication

IPD Sharing Access Criteria

Researchers must submit an acceptable research plan (goals of the proposed research, the specific hypotheses to be examined, justification for research and methods), be affiliated with a recognized research institution, have demonstrated expertise in the area of the proposed research project, and receive independent approval from their governing institutional review board. Data will be available for use only to answer the specific question(s) indicated in the research plan. The researchers must provide a list of variable names and an outline of how research findings will be disseminated; and will be asked to sign a data-sharing agreement that commits to: 1) not attempt to identify any individual participant, 2) secure the data using appropriate software technology, 3) and destroy or return all data once analyses are complete. All final datasets will be de-identified. Final authorship on manuscripts will require review and approval by the Principal Investigators of this study.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Environmental Exposure

Clinical Trials on Education curriculum

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Russia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe